CG
AMGN icon

Clarus Group’s Amgen AMGN Stock Holding History

Clarus Group’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-754
Closed -$236K – 113
2024
Q2 		$236K Buy
+754
New +$222K 0.1% 102

Other funds holding AMGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Clarus Group's AMGN Position: Q3 2024 in Review

Clarus Group sold out of Amgen (AMGN) in Q3 2024, closing a stake of 754 shares — an estimated $236K sold.

Clarus Group first reported a position in AMGN in Q2 2024 and held it in 1 quarter. The position peaked at $236K in Q2 2024. 2,824 funds tracked by Wall St. Rank hold AMGN as of Q3 2024.

  • Clarus Group reported no remaining Amgen position as of Q3 2024 after selling out during the quarter.
  • Clarus Group sold 754 Amgen shares in Q3 2024, an estimated $236K.
  • Clarus Group first reported a position in Amgen in Q2 2024 and held it in 1 quarter.
  • Clarus Group's Amgen position peaked at $236K in Q2 2024.
  • 2,824 funds tracked by Wall St. Rank held Amgen as of Q3 2024.

Based on Clarus Group's 13F filing for Q3 2024, filed 21 Oct 2024.